# Genomictree

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genomictree

- Industry: Biotechnology
- Headquarters: Daejeon, South Korea
- Website: www.genomictree.com
- Total disclosed funding: $8.5M
- Latest round: Series C (Sep 28, 2017)
- Investors on record: 2

## About

Based in Daejeon, South Korea and established in 2010, Genomictree, Inc. is a molecular diagnostic company which develops molecular diagnostic technology and product for the diagnostics of cancer and various infectious diseases. It provides DNA methylation biomarker-based non-invasive cancer molecular diagnostic product for cancer detection.

## Funding rounds

- Series C, Sep 28, 2017, $6.1M — KB Investment, Solidus Investment
- Series B, Jul 30, 2014, $2.4M — KB Investment, Solidus Investment

## Investors

- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series B, Series C
- Solidus Investment (https://capitalatlas.ai/funds/solidus-investment) — Series B, Series C